표적 치료제 시장 규모, 점유율 및 성장 분석 : 유형별, 용도별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Targeted Therapeutics Market size was valued at USD 75.25 Billion in 2024 and is poised to grow from USD 77.36 Billion in 2025 to USD 96.48 Billion by 2033, growing at a CAGR of 2.8% during the forecast period (2026-2033).

The global market for targeted therapeutics is witnessing rapid expansion, driven by the rising popularity of biologics and significant investments in the biotechnology sector. Monoclonal antibodies have emerged as key players from this surge, effectively inhibiting tumor cell proliferation. The anticipated growth of online pharmacies is expected to enhance the availability and sales of these specific therapeutic drugs. Furthermore, increased government spending on advanced healthcare infrastructure will play a pivotal role in propelling market growth. Additionally, heightened public awareness regarding targeted therapeutics continues to stimulate demand. Nevertheless, the market faces challenges, including potential side effects associated with targeted therapies, which may hinder its overall progress. Overall, the landscape is poised for robust growth amid evolving healthcare dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Targeted Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Targeted Therapeutics Market Segments Analysis

Global Targeted Therapeutics Market is segmented by Type, Application, Distribution Channel and region. Based on Type, the market is segmented into Monoclonal Antibodies and Small Molecule. Based on Application, the market is segmented into Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Multiple Sclerosis, Renal Cancer, Wet Age-related Macular Degeneration and Others (Ovarian Cancer, Fallopian Tube Cancer, Prostate Cancer, and Pancreatic Cancer). Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Targeted Therapeutics Market

The growth of the Global Targeted Therapeutics market is significantly propelled by the rising incidence of cancer worldwide, which has heightened the demand for innovative treatment options. As more individuals are diagnosed with various types of cancer, the need for effective targeted therapies becomes increasingly urgent. Additionally, the increasing disposable income of consumers allows for greater access to advanced healthcare solutions, leading to a surge in investment in targeted therapies. This combination of escalating cancer cases and improved financial capabilities among patients fosters a favorable environment for the development and adoption of targeted therapeutics, driving the market forward.

Restraints in the Global Targeted Therapeutics Market

The Global Targeted Therapeutics market faces significant challenges due to the side effects associated with targeted therapies and related drugs. These adverse effects can range from mild to severe, often impacting patient adherence and overall treatment outcomes. The complexity of these therapies can lead to unpredictable reactions, making it essential for healthcare providers to closely monitor patients. Additionally, the variability in individual responses to such treatments poses a restraint on market growth, as it complicates the development of universally effective therapeutic solutions. Thus, addressing these concerns is crucial for the continued advancement and acceptance of targeted therapeutics in clinical practice.

Market Trends of the Global Targeted Therapeutics Market

The global Targeted Therapeutics market is experiencing robust growth, driven by strategic collaborations, acquisitions, and innovative product launches within the industry. Leading companies are increasingly focusing on expanding their portfolios through the introduction of advanced therapies, which enhance treatment efficacy for various diseases. This competitive landscape not only fosters innovation but also stimulates market dynamics, as firms strive to meet rising healthcare demands. The growing emphasis on precision medicine and the development of complement-targeted therapies highlight the transformative nature of this sector, where specialized treatments are increasingly tailored to individual patient needs, thereby reinforcing the value proposition of targeted therapeutics.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Targeted Therapeutics Market Size by Type & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
  • Angiogenesis Inhibitors
  • HER-2 Targeted Agents
  • Anti-CD20 Monoclonal Antibodies
• Small Molecule
  • Tyrosine Kinase Inhibitors
  • mTOR Inhibitors
  • PARP Inhibitors

Global Targeted Therapeutics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Breast Cancer
• Colorectal Cancer
• Leukemia
• Lung Cancer
• Lymphoma
• Multiple Sclerosis
• Renal Cancer
• Wet Age-related Macular Degeneration
• Others (Ovarian Cancer, Fallopian Tube Cancer, Prostate Cancer, and Pancreatic Cancer)

Global Targeted Therapeutics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Targeted Therapeutics Market Size & CAGR (2026-2033)

• North America (Type, Application, Distribution Channel)
  • US
  • Canada
• Europe (Type, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gilead Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene (USA) (Acquired by Bristol-Myers Squibb)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Incyte (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations